Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Canine calcium phosphate uroliths.

J S Klausner, C A Osborne

    The Veterinary Clinics of North America. Small Animal Practice
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Calcium phosphate uroliths affect 3% of canine stone patients. Treatment focuses on reducing urine supersaturation by addressing factors like high urine pH and hypercalciuria.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ACVIM Small Animal Consensus Recommendations on the Treatment and Prevention of Uroliths in Dogs and Cats.

    Journal of veterinary internal medicine·2016
    Same author

    Fasting urinary calcium-to-creatinine and oxalate-to-creatinine ratios in dogs with calcium oxalate urolithiasis and breed-matched controls.

    Journal of veterinary internal medicine·2015
    Same author

    Effect of acetohydroxamic acid on dissolution of canine struvite uroliths.

    American journal of veterinary research·2013
    Same author

    Effect of acetohydroxamic acid on prevention of canine struvite uroliths.

    American journal of veterinary research·2013
    Same author

    The effect of disease on the urinary purine metabolite concentrations in dogs.

    The Veterinary record·2013
    Same author

    Recent shifts in the global proportions of canine uroliths.

    The Veterinary record·2013
    Same journal

    Regulation of Artificial Intelligence in Veterinary Medicine.

    The Veterinary clinics of North America. Small animal practice·2026
    Same journal

    Practical Steps Toward Antimicrobial Stewardship for the General Practitioner.

    The Veterinary clinics of North America. Small animal practice·2026
    Same journal

    Using Evidence-Based Veterinary Medicine and Artificial Intelligence to Support Clinical Decision Making in Veterinary Practice.

    The Veterinary clinics of North America. Small animal practice·2026
    Same journal

    Feline Asthma-Update on Diagnosis and Treatment Recommendations.

    The Veterinary clinics of North America. Small animal practice·2026
    Same journal

    Disease Prediction and Precision Veterinary Medicine: Applications, Opportunities, and Limitations of Artificial Intelligence in Small Animal Practice.

    The Veterinary clinics of North America. Small animal practice·2026
    Same journal

    The Moving Target of Companion Animal Infectious Diseases: Emerging Threats and Evolving Solutions.

    The Veterinary clinics of North America. Small animal practice·2026
    See all related articles

    Area of Science:

    • Veterinary Medicine
    • Urology
    • Biochemistry

    Background:

    • Calcium phosphate uroliths constitute a significant portion of canine urolithiasis.
    • Understanding the etiology of these stones is crucial for effective management.

    Purpose of the Study:

    • To identify predisposing factors for calcium phosphate urolith formation in dogs.
    • To outline initial medical therapy strategies for affected patients.

    Main Methods:

    • Analysis of canine urolith composition.
    • Identification of risk factors associated with calcium phosphate urolithiasis.
    • Review of current therapeutic approaches.

    Main Results:

    • Calcium phosphate uroliths are found in approximately 3% of canine stone patients.

    Related Experiment Videos

  • Key predisposing factors include elevated urine pH, hypercalciuria, and imbalances in crystallization inhibitors/promoters.

    • Conclusions:

    • Initial medical management should target the removal of factors causing urine supersaturation with calcium phosphate.
    • Addressing urine pH and hypercalciuria are primary therapeutic goals.